Clinical Study

A Randomized Phase II Trial For Patients With P16 Positive, Non-Smoking Associated, Locoregionally Advanced Oropharyngeal Cancer

Posted Date: May 15, 2019

  • Investigator: Jordan Kharofa
  • Type of Study: Drug

The purpose of this study is to compare any good and/or bad effects of using lower dose radiation therapy and chemotherapy to using lower dose radiation therapy alone. This study will allow the researchers to know whether these different approaches are better, the same, or worse than the usual appro

Criteria:

To Be Eligible For This Study, Patients Must Have Oropharyngeal Cancer Or A Specific Type That Appea

Keywords:

Nrg-Hn002, Oropharyngeal, Cancer, P16 Positive, Head & Neck

For More Information:

Uc Cancer Center
513-584-7698
kastla@uc.edu


  • This contact page is monitored Monday – Friday during business hours, 8 am to 5 pm EST. Do not rely on communication through this website for medical treatment or care. This website is not designed for such purposes.
    For questions regarding clinical studies at UC Health, contact us at ResearchStudies@UCHealth.com or (513) 245-3417.